| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K16130065 | CTRPv2 | pan-cancer | AAC | -0.0028 | 1 |
| mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | 0.0014 | 1 |
| mRNA | KIN001-266 | GDSC1000 | pan-cancer | AAC | -0.0011 | 1 |
| mRNA | GDC-0941 | CTRPv2 | pan-cancer | AAC | 0.00099 | 1 |
| mRNA | QL-VIII-58 | GDSC1000 | pan-cancer | AAC | -0.0011 | 1 |
| mRNA | NSC632839 | CTRPv2 | pan-cancer | AAC | -0.00081 | 1 |
| mRNA | SB 505124 | GDSC1000 | pan-cancer | AAC | -0.00075 | 1 |
| mRNA | GDC-0449 | FIMM | pan-cancer | AAC | 0.004 | 1 |
| mRNA | navitoclax:sorafenib (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.00073 | 1 |
| mRNA | BRD-K37390332 | CTRPv2 | pan-cancer | AAC | 0.0008 | 1 |